The preclinical discovery and development of orelabrutinib as a novel treatment option for B-cell lymphoid malignancies

.

Source: Expert Opinion on Drug Discovery - July 14, 2023 Category: Drugs & Pharmacology Authors: Pawe ł Robak Magda Witkowska Anna Wolska-Washer Tadeusz Robak Source Type: research